David Segal - Panaxia Labs Chief Executive Officer, Director
| PNAX Stock | ILA 7,954 213.00 2.61% |
CEO
David Segal is Chief Executive Officer, Director of Panaxia Labs Israel since 2019.
| Age | 43 |
| Tenure | 5 years |
| Phone | 972 7 2274 4144 |
| Web | https://panaxia.co.il |
Panaxia Labs Management Efficiency
The company has return on total asset (ROA) of (0.3003) % which means that it has lost $0.3003 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.3173) %, meaning that it generated substantial loss on money invested by shareholders. Panaxia Labs' management efficiency ratios could be used to measure how well Panaxia Labs manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CEO Age | ||
| Dan Rozner | Hiron Trade Investments Industr | 81 | |
| Shimon Abudraham | Amot Investments | 55 | |
| Arie Amir | Hiron Trade Investments Industr | 77 | |
Management Performance
| Return On Equity | -4.32 | |||
| Return On Asset | -0.3 |
Panaxia Labs Israel Leadership Team
Elected by the shareholders, the Panaxia Labs' board of directors comprises two types of representatives: Panaxia Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Panaxia. The board's role is to monitor Panaxia Labs' management team and ensure that shareholders' interests are well served. Panaxia Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Panaxia Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Ginossar, Internal Auditor | ||
| Jonathan Kolber, Chairman of the Board | ||
| Assi Rotbart, Chief Business Officer, Director | ||
| Dedi Segal, Founder Director | ||
| Sigal Eli, Chief Officer | ||
| Rinat Gazit, Independent Director | ||
| Eran Goldberg, Chief Technology Officer, Vice President | ||
| Asi Rotbert, Chief Director | ||
| David Segal, Chief Executive Officer, Director | ||
| Orit Weissman, Director | ||
| Tal YaronEldar, Director | ||
| Michal MaromBrikman, External Director | ||
| Yafa Levy, Chief Financial Officer | ||
| Moshe Reuveni, External Director | ||
| Tali YaronEldar, Director | ||
| Gil Benyamini, Vice President - Finance |
Panaxia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Panaxia Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.32 | |||
| Return On Asset | -0.3 | |||
| Profit Margin | (0.71) % | |||
| Operating Margin | (0.61) % | |||
| Current Valuation | 67.18 M | |||
| Shares Outstanding | 14.97 M | |||
| Shares Owned By Insiders | 68.66 % | |||
| Price To Book | 17.32 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 83.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Panaxia Labs Israel. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Panaxia Stock analysis
When running Panaxia Labs' price analysis, check to measure Panaxia Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panaxia Labs is operating at the current time. Most of Panaxia Labs' value examination focuses on studying past and present price action to predict the probability of Panaxia Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panaxia Labs' price. Additionally, you may evaluate how the addition of Panaxia Labs to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |